Integer Holdings Corporation (ITGR)
NYSE: ITGR · Real-Time Price · USD
69.84
-0.78 (-1.10%)
At close: Dec 5, 2025, 4:00 PM EST
69.25
-0.59 (-0.84%)
After-hours: Dec 5, 2025, 7:41 PM EST

Integer Holdings Revenue

In the year 2024, Integer Holdings had annual revenue of $1.72B with 10.35% growth.

Revenue (ttm)
$1.72B
Revenue Growth
+10.35%
P/S Ratio
1.31
Revenue / Employee
$166,461
Employees
11,000
Market Cap
2.45B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20241.72B160.94M10.35%
Dec 31, 20231.56B224.38M16.85%
Dec 31, 20221.33B110.20M9.02%
Dec 31, 20211.22B147.64M13.75%
Dec 31, 20201.07B-184.65M-14.68%
Dec 31, 20191.26B43.08M3.55%
Dec 28, 20181.22B78.93M6.95%
Dec 29, 20171.14B60.58M5.63%
Dec 30, 20161.08B275.09M34.37%
Jan 1, 2016800.41M112.63M16.38%
Jan 2, 2015687.79M23.84M3.59%
Jan 3, 2014663.95M17.77M2.75%
Dec 28, 2012646.18M77.36M13.60%
Dec 30, 2011568.82M35.40M6.64%
Dec 31, 2010533.43M11.60M2.22%
Jan 1, 2010521.82M-24.82M-4.54%
Jan 2, 2009546.64M227.90M71.50%
Dec 28, 2007318.75M47.60M17.56%
Dec 29, 2006271.14M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
UnitedHealth Group435.16B
Johnson & Johnson92.15B
Merck & Co.64.24B
AbbVie59.64B
Eli Lilly and Company59.42B
AstraZeneca58.13B
Novartis AG56.37B
Novo Nordisk49.58B
Revenue Rankings